On March 25, 2026 the Jeffrey Modell Foundation (JMF) will host Donald B. Kohn, MD, a Distinguished Professor at the ...

ROAS Suite today launched its AI ad creation platform worldwide, enabling ecommerce brands to generate production-ready video ...

Qodo, the AI code review platform, today announced a new integration with Azure DevOps, expanding its enterprise ecosystem and making AI-driven code review available directly inside one of the most ...

Rutgers Health identifies 556 genes that prepare the uterus for pregnancy, paving the way for improved infertility diagnosis and personalized treatments.

Pharming Group has transitioned from a speculative play to a fundamentally attractive, cash-generating rare disease company.

A gene therapy that patients breathe in has been found to shrink lung tumours by inserting immune-boosting genes into ...

After facing a delayed decision deadline and a clinical hold, Regenxbio’s Hunter syndrome gene therapy has been rejected by ...

As Eli Lilly awaits an FDA approval decision for its oral GLP-1 orforglipron, the pharma has discarded three clinical-stage ...

The FDA recommended that REGENXBIO run a new study, treat more patients and include a placebo arm to support a resubmission for the gene therapy RGX-121.

A research team has successfully demonstrated the world's first gene-editing treatment for Leber's hereditary optic ...

Dr. Rebecca Ahrens-Nicklas and Dr. Kiran Musunru crafted a bespoke treatment that has successfully corrected the genetic ...

All participants had adverse events, but most were moderate in severity ...